Text Size

Wound Healing Response After Bleb-Forming Glaucoma Surgery With a SIBS Microshunt in Rabbits

van Mechelen R.J.S., Wolters J.E.J., Herfs M., Bertens C.J.F., Gijbels M., Pinchuk L., Gorgels T.G.M.F., Beckers H.J.M.


  • 2022
  • Translational vision science & technology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Preclinical development

  • Affiliations

    University Eye Clinic Maastricht, Maastricht University Medical Center+, Maastricht, Netherlands; Department of Ophthalmology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Chemelot Institute for Science and Technology, Maastricht, Netherlands; Department of Pathology, Cardiovascular Research Institute Maastricht, School for Oncology and Developmental Biology, Maastricht University, Maastricht, Netherlands; Department of Medical Biochemistry, Experimental Vascular Biology, Amsterdam UMC, University of Amsterdam, Amsterdam, Netherlands; InnFocus, Inc., Miami, FL, United States

Related Publications

Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.


Efficacy and Safety of a Preservative-Free Latanoprost Cationic Emulsion in Patients with Open-Angle Glaucoma and Concurrent Ocular Surface Disease: A Randomized Phase 2 Study.

Bacharach, Jason; McLaurin, Eugene B.; Silverstein, Steven; Amrane, Mourad; Garrigue, Jean-Sebastien; Ismail, Dahlia; Flynn, William J.; Catiolanze Phase 2 study group


Assessment of Brain-Derived Neurotrophic Factor on Retinal Structure and Visual Function in Rodent Models of Optic Nerve Crush

Taniguchi T.; Sharif N.A.; Ota T.; Farjo R.A.; Rausch R.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022